Novartis' Leqvio Gets FDA Approval For New Indication Enabling First-line Use
31/7 23:28
(RTTNews) - Novartis announced Thursday said that the US Food and Drug Administration (FDA) has approved a label update for Leqvio (inclisiran), enabling its use as monotherapy along with diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C) in adults with hyper...